Kepprdain syrup

composition:

Each 1ml contains:
Levetiracetam 100mg

Indication:

Indicated as mono therapy in the treatment of partial onset seizures with or without secondary generalization in adult and adolescents from 16 years of age with newly diagnosed epilepsy

-In the treatment of partial onset seizures with or without secondary generation in adults, Adolescents and children from 4 year of age with epilepsy.

-In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy

-In the treatment of primary generalized tonic-clonic seizures in adult and adolescent from 12 years of age with idiopathic generalized epilepsy.